Myriad Genetics
MYGN
#6784
Rank
ยฃ0.46 B
Marketcap
ยฃ5.02
Share price
3.21%
Change (1 day)
-53.78%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -ยฃ0.31 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are ยฃ0.82 Billion. In 2024 the company made an earning of -ยฃ89.55 Million, an increase over its 2023 earnings that were of -ยฃ0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.31 Billion245.17%
2024 -ยฃ89.55 Million-53.49%
2023 -ยฃ0.2 Billion88.72%
2022 -ยฃ0.11 Billion172.08%
2021 -ยฃ37.5 Million
2019 -ยฃ19.53 Million-175.14%
2018 ยฃ25.98 M-70.81%
2017 ยฃ89.02 M22.22%
2016 ยฃ72.83 M-38.8%
2015 ยฃ0.11 B-6.12%
2014 ยฃ0.12 B-41.07%
2013 ยฃ0.21 B46.67%
2012 ยฃ0.14 B15.84%
2011 ยฃ0.12 B17.6%
2010 ยฃ0.10 B-15.96%
2009 ยฃ0.12 B
2007 -ยฃ30.95 Million40.96%
2006 -ยฃ21.96 Million
2003 -ยฃ25.5 Million34.8%
2002 -ยฃ18.92 Million89.21%
2001 -ยฃ10 Million3.93%
2000 -ยฃ9.62 Million21.76%
1999 -ยฃ7.9 Million-25.61%
1998 -ยฃ10.62 Million38.83%
1997 -ยฃ7.65 Million-24.26%
1996 -ยฃ10.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-ยฃ0.63 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-ยฃ0.73 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-ยฃ25.97 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.50 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.04 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA